GT Biopharma, Inc. (GTBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.33M |
| Enterprise Value | -2.48M |
| P/E Ratio | -0.05 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.29 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.08 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -3.82 |
| Return On Equity | -4.43 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -28.23M |
| Net Income | -28.35M |
| Diluted EPS | -156.25 |
Balance Sheet
| Total Cash | 4.96M |
| Total Cash/Share | 3.19 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.61 |
| Book Value Per Share | 2.3 |
Price History
| 52-Week Change | -66.17 |
| 52-Week High | 28.75 |
| 52-Week Low | 4.91 |
| Moving Average 50 Days | 6.72 |
| Moving Average 200 Days | 9.68 |
Statistics
| Average Volume | 64,960 |
| Shares Outstanding | 1.26M |
| % Held by Institutions | 5.42 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:25 |
| Last Split Date | September 08, 2026 |
AD
